TMC Life Sciences Bhd
KLSE:TMCLIFE
Intrinsic Value
The intrinsic value of one TMCLIFE stock under the Base Case scenario is 0.34 MYR. Compared to the current market price of 0.45 MYR, TMC Life Sciences Bhd is Overvalued by 24%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
TMC Life Sciences Bhd
Fundamental Analysis


Revenue & Expenses Breakdown
TMC Life Sciences Bhd
Balance Sheet Decomposition
TMC Life Sciences Bhd
Current Assets | 250.7m |
Cash & Short-Term Investments | 172.4m |
Receivables | 66.3m |
Other Current Assets | 12m |
Non-Current Assets | 927.4m |
Long-Term Investments | 2.1m |
PP&E | 718.9m |
Intangibles | 206.2m |
Other Non-Current Assets | 193k |
Free Cash Flow Analysis
TMC Life Sciences Bhd
MYR | |
Free Cash Flow | MYR |
Earnings Waterfall
TMC Life Sciences Bhd
Revenue
|
326.4m
MYR
|
Cost of Revenue
|
-107.4m
MYR
|
Gross Profit
|
218.9m
MYR
|
Operating Expenses
|
-209.8m
MYR
|
Operating Income
|
9.1m
MYR
|
Other Expenses
|
-6.9m
MYR
|
Net Income
|
2.2m
MYR
|
TMCLIFE Profitability Score
Profitability Due Diligence
TMC Life Sciences Bhd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
TMC Life Sciences Bhd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
TMCLIFE Solvency Score
Solvency Due Diligence
TMC Life Sciences Bhd's solvency score is 54/100. The higher the solvency score, the more solvent the company is.
Score
TMC Life Sciences Bhd's solvency score is 54/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TMCLIFE Price Targets Summary
TMC Life Sciences Bhd
Dividends
Current shareholder yield for TMCLIFE is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one TMCLIFE stock under the Base Case scenario is 0.34 MYR.
Compared to the current market price of 0.45 MYR, TMC Life Sciences Bhd is Overvalued by 24%.